Novel therapies to enhance anti-tumour immunity

增强抗肿瘤免疫力的新疗法

• 批准号: nhmrc : 1139626
• 负责人: A/Pr Ilia Voskoboinik
• 金额: $ 53.93万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/novel-therapies-enhance-tumour-immunity/1319044
• 关键词: Novel; therapies; enhance; anti; tumour

Immunotherapy is a new approach to treat cancer, and works by promoting the immune system to attack cancer. Immunotherapies, such as checkpoint blockade and adoptive T cell therapy, are proving to be very successful in certain human cancers. However, combining immunotherapy with drugs that cause cancer cell death may be more effective. This project will investigate the potential of combining immunotherapy with a novel anti-cancer drug, in order to develop more effective treatments for cancer.

免疫疗法是一种治疗癌症的新方法，通过促进免疫系统来攻击癌症。免疫疗法，如检查点阻断和过继T细胞疗法，被证明在某些人类癌症中非常成功。然而，将免疫疗法与导致癌细胞死亡的药物结合起来可能更有效。该项目将研究将免疫疗法与一种新型抗癌药物相结合的潜力，以开发更有效的癌症治疗方法。